Cardiac biomarkers in acute myocardial infarction
SJ Aldous - International journal of cardiology, 2013 - Elsevier
Each year, a large number of patients are seen in the Emergency Department with
presentations necessitating investigation for possible acute myocardial infarction. Patients …
presentations necessitating investigation for possible acute myocardial infarction. Patients …
[HTML][HTML] Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC/ERS-based risk …
RL Benza, M Gomberg-Maitland, CG Elliott, HW Farber… - Chest, 2019 - Elsevier
Background Pulmonary arterial hypertension is a progressive, fatal disease. Published
treatment guidelines recommend treatment escalation on the basis of regular patient …
treatment guidelines recommend treatment escalation on the basis of regular patient …
Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction
Acute myocardial infarction (AMI) is the leading cause of death worldwide, with early
diagnosis still being difficult. Promising new cardiac biomarkers such as troponins and …
diagnosis still being difficult. Promising new cardiac biomarkers such as troponins and …
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for …
R Prondzinsky, H Lemm, M Swyter… - Critical care …, 2010 - journals.lww.com
Objective: Patients undergoing percutaneous coronary intervention (PCI) for acute
myocardial infarction with cardiogenic shock (CS) are often treated with intra-aortic balloon …
myocardial infarction with cardiogenic shock (CS) are often treated with intra-aortic balloon …
Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?
OS Dhillon, HK Narayan, SQ Khan, D Kelly… - International journal of …, 2013 - Elsevier
Background Soluble ST2 is a marker of cellular stress and injury whose natural ligand is
interleukin-33. We investigate, for the first time, the relationship of IL-33 and ST2 with death …
interleukin-33. We investigate, for the first time, the relationship of IL-33 and ST2 with death …
Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal …
J Brozaitiene, N Mickuviene, A Podlipskyte… - BMC cardiovascular …, 2016 - Springer
Background Altered thyroid function and increased rates of N-terminal pro-B-Type natriuretic
peptide (NT-pro-BNP) are highly prevalent in coronary artery disease (CAD) patients with …
peptide (NT-pro-BNP) are highly prevalent in coronary artery disease (CAD) patients with …
Plasma brain natriuretic peptide (BNP) as an indicator of left ventricular function, early outcome and mechanical complications after acute myocardial infarction
A Fazlinezhad, MK Rezaeian… - Clinical Medicine …, 2011 - journals.sagepub.com
Aims This study investigated the prognostic value of B type natriuretic peptide (BNP) in acute
myocardial infarction (AMI) patients and its relation with left ventricular function and post …
myocardial infarction (AMI) patients and its relation with left ventricular function and post …
N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome
SQ Khan, H Narayan, KH Ng, OS Dhillon… - Clinical …, 2009 - portlandpress.com
The GRACE (Global Registry of Acute Coronary Events) risk score has been shown to offer
predictive power with regard to death and AMI (acute myocardial infarction) in patients with …
predictive power with regard to death and AMI (acute myocardial infarction) in patients with …
[HTML][HTML] Risk stratification in patients with coronary artery disease: a practical walkthrough in the landscape of prognostic risk models
S Buccheri, P D'Arrigo, G Franchina… - Interventional …, 2018 - ncbi.nlm.nih.gov
Although a combination of multiple strategies to prevent and treat coronary artery disease
(CAD) has led to a relative reduction in cardiovascular mortality over recent decades, CAD …
(CAD) has led to a relative reduction in cardiovascular mortality over recent decades, CAD …
Change of BNP between admission and discharge after ST-elevation myocardial infarction (Killip I) improves risk prediction of heart failure, death, and recurrent …
LSF Carvalho, LAC Bogniotti… - … Heart Journal: Acute …, 2019 - academic.oup.com
Objective In ST-elevation myocardial infarction, 7–15% of patients admitted as Killip I will
develop symptomatic heart failure or decreased ejection fraction. However, available clinical …
develop symptomatic heart failure or decreased ejection fraction. However, available clinical …